期刊文献+

PCNA表达与脑胶质瘤复发的相关性分析 被引量:8

The Correlation between the Expression of Proliferation Cell Nuclear Antigen and the Recurrence of Glioma
下载PDF
导出
摘要 目的探讨增殖细胞核抗原(proliferation cell nuckearantigen,PCNA)表达在胶质瘤术后复发中的意义。方法通过对焦作市人民医院神经外科2002年1月~2007年12月手术后病理检查证实为胶质瘤的53例患者的电话复访、信件回访及门诊复诊的回访,以复查头颅CT或头颅MR I为标准,择出未见复发组32例,复发组21例,对其病理组织采用链霉菌抗生物素蛋白-过氧化物酶连接法(即S-P法)进行PCNA的测定,观察PCNA在不同组别中的表达差异。结果复发组PCNA阳性表达率是71.43%(15/21),未复发组是21.88%(7/32),两组间有明显差异(P<0.05)。结论PCNA表达可作为预测脑胶质瘤是否复发的参考因素。 Objective To investigate the expression of the proliferation cell nuclear antigen (PCNA) and its correlation with the recurrence of glioma after surgical treatment. Methods The expression of PCNA was detected by immunohistochemical S -P method in the tissues from 53 patients with glioma treated by surgical method from January ,2002 to December,2007 in our hospital. Of the 53 patients,21 had recurrent tumors and 32 were free from recurrence based on CT or MRI. The expression of PCNA was correlated with the local tumor controls. Results The positive expression rate of PCNA was 71.43% ( 15/21 ) and 21.88% (7/32) in patients with and without tumor recurrence, and the difference was statistically significant (P 〈 0.05 ) . Conclusion The expression of PCNA might be an prognostic marker of local recurrence in the patients with glioma treated by surgical method.
出处 《实用癌症杂志》 2009年第5期455-456,461,共3页 The Practical Journal of Cancer
关键词 胶质瘤 复发 增殖细胞核抗原 Glioma Recurrence Proliferation cell nuckearantigen(PCNA)
  • 相关文献

参考文献4

二级参考文献43

  • 1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:214
  • 2王东,史景泉.肝细胞癌增殖细胞核抗原免疫组化研究[J].癌症,1996,15(2):112-114. 被引量:6
  • 3张新立,史景泉,王晓东,王东.人肝细胞癌与癌旁肝细胞增殖活性的定量研究[J].第三军医大学学报,1996,18(1):36-39. 被引量:1
  • 4许良中.关于核仁组织区(AgNOR)研究工作的标准化方案[J].中国肿瘤临床,1996,23(5):377-377.
  • 5Cunningham JM, Kimmel DW, Scheithauer BW,et al. Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value [ J ]. J Neurosurg, 1997, 86:121 - 130.
  • 6Camby I, Lefranc F, Titeca G,et al. Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade Ⅱ and Ⅲ astrocytic tumours[ J]. Neuropathol Appl Neurobiol, 2000, 26 ( 1 ): 76 - 90.
  • 7Korshunov A, Golanov A, Sycheva R. Immunohistochemical markers for prognosis of cerebral glioblastomas [ J ]. J Neurooncol,2002, 58(3): 217 -236.
  • 8Kayaselcuk F, Zorludemir S, Gumurduhu D,et al. PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade[J]. J Neurooncol, 2002, 57(2): 115-121.
  • 9Kim DK, Hoyt J, Bacchi C,et al. Detection of proliferating cell nuclear antigen in gliomas and adjacent resection margins[ J]. Neurosurg, 1993, 33:619 -626.
  • 10Verstegen M J, Leenstra DT, Ijlst-Keizers H,et al. Proliferation-and apoptosis-related proteins in intracranial ependymomas:an immunohistochemical analysis[ J]. J Neurooncol, 2002, 56( 1 ): 21 -28.

共引文献45

同被引文献87

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部